Purpose: This study aims to develop and validate a deep learning framework designed to eliminate the second CT scan of dual-tracer total-body PET/CT imaging.
Methods: We retrospectively included three cohorts of 247 patients who underwent dual-tracer total-body PET/CT imaging on two separate days (time interval:1-11 days). Out of these, 167 underwent [Ga]Ga-DOTATATE/[F]FDG, 50 underwent [Ga]Ga-PSMA-11/[F]FDG, and 30 underwent [Ga]Ga-FAPI-04/[F]FDG. A deep learning framework was developed that integrates a registration generative adversarial network (RegGAN) with non-rigid registration techniques. This approach allows for the transformation of attenuation-correction CT (ACCT) images from the first scan into pseudo-ACCT images for the second scan, which are then used for attenuation and scatter correction (ASC) of the second tracer PET images. Additionally, the derived registration transform facilitates dual-tracer image fusion and analysis. The deep learning-based ASC PET images were evaluated using quantitative metrics, including mean absolute error (MAE), peak signal-to-noise ratio (PSNR), and structural similarity index measure (SSIM) across the whole body and specific regions. Furthermore, the quantitative accuracy of PET images was assessed by calculating standardized uptake value (SUV) bias in normal organs and lesions.
Results: The MAE for whole-body pseudo-ACCT images ranged from 97.64 to 112.59 HU across four tracers. The deep learning-based ASC PET images demonstrated high similarity to the ground-truth PET images. The MAE of SUV for whole-body PET images was 0.06 for [Ga]Ga-DOTATATE, 0.08 for [Ga]Ga-PSMA-11, 0.06 for [Ga]Ga-FAPI-04, and 0.05 for [F]FDG, respectively. Additionally, the median absolute percent deviation of SUV was less than 2.6% for all normal organs, while the mean absolute percent deviation of SUV was less than 3.6% for lesions across four tracers.
Conclusion: The proposed deep learning framework, combining RegGAN and non-rigid registration, shows promise in reducing CT radiation dose for dual-tracer total-body PET/CT imaging, with successful validation across multiple tracers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00259-025-07113-5 | DOI Listing |
Pancreatic ductal adenocarcinoma (PDAC) is highly susceptible to metastasis, making early detection of metastases and associated risk factors crucial for effective management. This study aimed to assess the performance of fluorine (F)- fibroblast activation protein inhibitor-04 (F-FAPI-04) positron emission tomography/computed tomography (PET/CT) in detecting metastasis and predicting pathological characteristics and risk factors in 67 PDAC patients. Comparisons were made with F-fluorodeoxyglucose (F-FDG) PET/CT.
View Article and Find Full Text PDFSci Technol Adv Mater
February 2025
Department of Bioengineering, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Positron emission tomography (PET)/fluorescence dual-modal imaging combines deep penetration and high resolution, making it a promising approach for tumor diagnostics. Semiconductor nanocrystals, known as quantum dots (QDs), have garnered significant attention for fluorescence imaging owing to their tunable emission wavelength, high quantum yield, and excellent photostability. Among these QDs, heavy metal-free InP-based QDs have emerged as a promising candidate, addressing concerns regarding heavy metal-related toxicity.
View Article and Find Full Text PDFCurr Opin Oncol
February 2025
Department of Diagnostic Radiology and Nuclear Medicine.
Purpose Of Review: In the era of precision medicine, the introduction of FDA-approved prostate-specific membrane antigen (PSMA) targeting tracers has revolutionized prostate cancer imaging. These tracers enable functional positron emission tomography (PET) imaging, allowing for precise identification of the location and extent of prostate cancer spread. This review serves as a practical guide for multidisciplinary teams caring for prostate cancer patients, outlining the current approved uses of PET imaging with PSMA tracers and exploring its future applications.
View Article and Find Full Text PDFBMC Rheumatol
March 2025
Department of Medicine, Albury-Wodonga Health, Albury, NSW, Australia.
Background: Giant cell arteritis (GCA) is a vasculitis primarily affecting medium- and large-sized arteries. The diagnosis may be challenging and lead to delays in treatment. Cerebrospinal fluid (CSF) pleocytosis is an uncommon association but may occur due to central nervous system (CNS) vasculitis or pachymeningitis.
View Article and Find Full Text PDFClin Nucl Med
March 2025
Department of Nuclear Medicine, Imaging Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
A 46-year-old woman with primary hyperparathyroidism and negative sestamibi parathyroid scan was referred for 18F-fluorocholine (18F-FCH) positron emission tomography (PET/CT) scan to help localize parathyroid adenoma. FCH PET/CT scan identified a hyperfunctioning parathyroid gland in the left neck. In addition, there was unusually intense unilateral FCH uptake in the right breast corresponding to dense soft tissue.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!